Analysis of Editas Medicine Inc. (EDIT). Value Article. Ahhhhh, the stock market, where truth lies behind the scenes (or in a dark pool). Yes. EDIT Company Profile Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range. A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. EDIT - Editas Medicine, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). View today's Editas Medicine Inc stock price and latest EDIT news and analysis. Create real-time notifications to follow any changes in the live stock.
View the latest Editas Medicine Inc. (EDIT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest updates on Editas Medicine, Inc. Common Stock (EDIT) after hours trades, after hours share volumes, and more. Make informed investments with. Editas Medicine Inc EDIT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date12/06/23 · 52 Week Low · On average, Wall Street analysts predict that Editas Medicine's share price could reach $ by Aug 8, The average Editas Medicine stock price. Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information. View Editas Medicine, Inc. EDIT stock quote prices, financial information, real-time forecasts, and company news from CNN. Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at. Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. Editas Medicine stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The latest Editas Medicine stock prices, stock quotes, news, and EDIT history to help you invest and trade smarter.
View Editas Medicine, Inc EDIT investment & stock information. Get the latest Editas Medicine, Inc EDIT detailed stock quotes, stock data, Real-Time ECN. Editas shares jump 9% on positive news from sickle-cell study. Shares of Editas Medicine Inc. rallied % in premarket trading on Tuesday after the company. Discover real-time Editas Medicine, Inc. Common Stock (EDIT) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Analysis of Editas Medicine Inc. (EDIT). Value Article. Ahhhhh, the stock market, where truth lies behind the scenes (or in a dark pool). Yes. Editas (EDIT) reports lower-than-expected second-quarter results as both earnings and revenues miss estimates. The stock falls %. Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases. Editas Medicine Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - The current price of EDIT is USD — it has increased by % in the past 24 hours. Watch Editas Medicine, Inc. stock price performance more closely on the. Stock Information. Stock Quote & Chart · Investor FAQs · Contact. Investors. Overview. Stock Quote. NASDAQ: EDIT. $ Change; + (+%): Volume.
Editas Medicine, Inc. is a clinical-stage genome editing company. The Company is focused on developing potentially transformative genomic medicines. In the current month, EDIT has received 10 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. EDIT average Analyst price target in the past 3 months is $ EDIT - Editas Medicine Inc - Stock screener for investors and traders, financial visualizations. EDIT stock analysis and financial data, including key statistics and ratios, valuations, historical price and financial performance of Editas Medicine. Get the latest Editas Medicine Inc. (EDIT) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.